Cite
Porcellini S, Asperti C, Valentinis B, et al. The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms. Oncoimmunology. 2015;4(10):e1041700doi: 10.1080/2162402X.2015.1041700.
Porcellini, S., Asperti, C., Valentinis, B., Tiziano, E., Mangia, P., Bordignon, C., Rizzardi, G. P., & Traversari, C. (2015). The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms. Oncoimmunology, 4(10), e1041700. https://doi.org/10.1080/2162402X.2015.1041700
Porcellini, Simona, et al. "The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms." Oncoimmunology vol. 4,10 (2015): e1041700. doi: https://doi.org/10.1080/2162402X.2015.1041700
Porcellini S, Asperti C, Valentinis B, Tiziano E, Mangia P, Bordignon C, Rizzardi GP, Traversari C. The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms. Oncoimmunology. 2015 Jul 01;4(10):e1041700. doi: 10.1080/2162402X.2015.1041700. eCollection 2015 Oct. PMID: 26451306; PMCID: PMC4589061.
Copy
Download .nbib